Communications Biology (Nov 2022)

A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements

  • Robert J. Kimmerling,
  • Mark M. Stevens,
  • Selim Olcum,
  • Anthony Minnah,
  • Madeleine Vacha,
  • Rachel LaBella,
  • Matthew Ferri,
  • Steven C. Wasserman,
  • Juanita Fujii,
  • Zayna Shaheen,
  • Srividya Sundaresan,
  • Drew Ribadeneyra,
  • David S. Jayabalan,
  • Sarita Agte,
  • Adolfo Aleman,
  • Joseph A. Criscitiello,
  • Ruben Niesvizky,
  • Marlise R. Luskin,
  • Samir Parekh,
  • Cara A. Rosenbaum,
  • Anobel Tamrazi,
  • Clifford A. Reid

DOI
https://doi.org/10.1038/s42003-022-04270-3
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 14

Abstract

Read online

A pipeline for drug sensitivity testing using cell mass from sample collection to data analysis is presented.